NCT06336759已完成不适用
Prospective Clinical Trial Evaluating the Safety and Efficacy of Restylane Lyft and Defyne for Contouring the Jawline
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 40
- 试验地点
- 2
- 主要终点
- Frequency of subjects displaying at least a one grade improvement since Baseline, on the Raspaldo (2008) Jawline Scale
研究概览
简要总结
The study's goal is to assess the safety and efficacy of two hyaluronic acid products, Restylane Lyft and Defyne, for contouring the jawline and chin, in order to address concerns regarding contour deficiencies among patients seeking aesthetic treatments.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •A score > 1 on the Raspaldo Jawline Scale, as assessed by the treating physician at Baseline. A possible secondary deficit of the chin is allowed.
- •Males and females aged > 18 years.
- •Ability to adequately understand the verbal explanations and the written subject information provided in local language and ability and willingness to give consent to participate in the study.
- •Signed and dated informed consent to participate in the study.
- •If female of childbearing potential: a negative urine pregnancy test before all treatments is required.
排除标准
- •Current pregnancy or lactation [sexually active women of childbearing age must agree to use medically acceptable methods of contraception for the duration of this study (e.g., oral contraceptives, condoms, intrauterine device, shot/injection, patch)].
- •Subjects presenting with known allergy to hyaluronic acid fillers or amide local anesthetics.
- •Subjects presenting with porphyria.
- •Subjects with active disease, such as inflammation, infection or tumors, in or near the intended treatment sites.
- •Subjects with history of bleeding disorders or subjects taking thrombolytics or anticoagulants.
- •Subjects taking inhibitors of platelet aggregation (e.g., Aspirin or other non-steroid anti-inflammatory drugs [NSAIDs]), within 2 weeks before treatment.
- •Subjects using immunosuppressants.
- •History of permanent implants in the lower face.
- •History of other treatment/procedure that, in the treating investigator's opinion, would interfere with the study injections and/or study assessments or exposes the subject to undue risk by study participation.
- •Visible markings that in the treating investigator's opinion, may interfere with results or assessments.
- •Inability to comply with follow-up and abstain from other treatments in the region of interest during the study period.
- •Heavy smokers, classified as smoking more than 12 cigarettes per day.
- •History of severe or multiple allergies manifested by anaphylaxis.
- •Previous tissue revitalization therapy in the treatment area within 6 months before treatment with laser or light, mesotherapy, radiofrequency, ultrasound, cryotherapy, chemical peeling, or dermabrasion.
- •Previous treatment with neurotoxins in the area under assessment, within 6 months prior to enrolment.
- •Previous treatment with soft tissue fillers in the area under assessment, within 12 months prior to enrolment.
- •Cancer or precancer in the treatment area (e.g., actinic keratosis).
- •Subjects with a tendency to form hypertrophic scars or any other healing disorders.
- •Subjects with a mean skin thickness in the treatment areas between 1.29mm and 1.49mm (ie, "normal" thickness), as determined by ultrasound at Baseline, to ensure no overlap between the two strata (ie, thin and thick skin).
结局指标
主要结局
Frequency of subjects displaying at least a one grade improvement since Baseline, on the Raspaldo (2008) Jawline Scale
时间窗: Baseline to Month 3
The Jawline (Raspaldo 2008) Scale is a 5 point Likert scale ranging from "severe depression or atrophy" (grade 4) to "normal" (grade 1) used by the blinded evaluator to assess the jawline
Frequency of subjects having at least "improved" since Baseline, as per the Global Aesthetic Improvement Scale (GAIS)
时间窗: Baseline to Month 3
The Global Aesthetic Improvement Scale is a graded Likert scale with assessments ranging form "very much worse" (grade -3) to "very much improved" (grade 3).
次要结局
- Frequency of subjects displaying at least a one grade improvement since Baseline, on the Raspaldo Jawline Scale(Baseline to Month 6)
- Frequency of subjects having at least "improved" since Baseline, as per the Global Aesthetic Improvement Scale (GAIS)(Baseline to Month 6)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Study to Evaluate Efficacy, Safety and Injection Technique of Restylane Lip Volume and Restylane Lip RefreshInjection TechniquesNCT01428024Galderma R&D60
已完成
不适用
Safety and Efficacy of Restylane Lidocaine and Restylane Perlane Lidocaine for Facial Augmentation in Asian PopulationHealthy VolunteersNCT02565784Galderma R&D100
已完成
1 期
Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in AdultsGenital Herpes Simplex Type 2NCT02030301Vical165
已完成
1 期
Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid TumorAdvanced Solid TumorNCT03239145Dana-Farber Cancer Institute62
Unknown
1 期
Intranasal Human FGF-1 for Subjects With Parkinson's DiseaseParkinson DiseaseNCT05493462Zhittya Genesis Medicine, Inc.4